Long Beach, CA
File #: 16-0111    Version: 1 Name: DHHS - Biomedical HIV Prevention Svcs
Type: Contract Status: CCIS
File created: 1/21/2016 In control: City Council
On agenda: 2/9/2016 Final action: 2/9/2016
Title: Recommendation to authorize City Manager, or designee, to execute a Master Agreement between the City of Long Beach and the County of Los Angeles Department of Public Health (LADPH), and any subsequent amendments, to provide Biomedical Human Immunodeficiency Virus Prevention Services for a term effective upon the date of execution and continuing through December 31, 2023, with an option to extend the agreement for two additional one-year terms at the discretion of the LADPH through December 31, 2025. (Citywide)
Sponsors: Health and Human Services
Indexes: Agreements
Attachments: 1. 020916-C-3sr.pdf
Related files: 34207_005, 34207_003, 34207_001, 34207_002, 34750_000, 34207_000, 34207_004, 34750_001, 34207_006

TITLE

Recommendation to authorize City Manager, or designee, to execute a Master Agreement between the City of Long Beach and the County of Los Angeles Department of Public Health (LADPH), and any subsequent amendments, to provide Biomedical Human Immunodeficiency Virus Prevention Services for a term effective upon the date of execution and continuing through December 31, 2023, with an option to extend the agreement for two additional one-year terms at the discretion of the LADPH through December 31, 2025.  (Citywide)

 

DISCUSSION

In 2012, the first biomedical HIV prevention intervention for HIV negative individuals was implemented with the approval of the Food and Drug Administration (FDA) of the drug Truvada for use as a Pre-exposure prophylaxis, also known as PrEP.  PrEP, is a HIV prevention prescription medication (Truvada) for people who do not have HIV, but who are at substantial risk of contracting HIV.  PrEP, as a biomedical prevention intervention, has been proven safe and effective in reducing the risk of HIV infection in people who are at high risk by up to 92 percent when taken consistently.

 

The Department of Health & Human Services (Health Department) HIV Care Clinic’s medical providers have nearly three years of experience in providing biomedical HIV prevention services as co-investigators of a multi-year study led by the California Collaborative Treatment Group (CCTG), sponsored by the California Research Program (CHRP) and the Centers for Disease Control (CDC).

 

In October 2015, the Health Department began expanding its PrEP services to include those outside of the current study as a billable service under Medi-Cal, Medicare and other third party payers.  This agreement will enable the Health Department to be eligible to contract with the LADPH to provide biomedical HIV prevention services in the community targeting individuals who are uninsured/underinsured and at substantial risk for contracting HIV.

 

This matter was reviewed by Deputy City Attorney Linda Vu on January 11, 2016 and by Budget Management Officer Victoria Bell on January 15, 2016.

 

TIMING CONSIDERATIONS

City Council is requested on February 9, 2016, in order for the Health Department to apply for the Biomedical HIV Prevention Services upcoming RFP.

 

FISCAL IMPACT

If the agreement with the LADPH is approved and implemented, then the Health Department will have the opportunity to apply for the upcoming Biomedical HIV Prevention Services RFP, which could result in additional funding based on a fee-for-service reimbursement basis.  No match or in-kind service mandate is required, and there is no local job impact associated with this action.

 

SUGGESTED ACTION

Approve recommendation.

 

 

Respectfully Submitted,

KELLY COLOPY, DIRECTOR

HEALTH AND HUMAN SERVICES

 

 

 

 

APPROVED:

 

PATRICK H. WEST

CITY MANAGER